MarketCap
Facebook
X
Telegram
Savara Kurzfristige Verbindlichkeiten | SVRA
Kurzfristige Verbindlichkeiten Jährlich Savara
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.4 M | 14.7 M | 10.6 M | 5.87 M | 14.7 M | 8.17 M | 10.9 M | 7.25 M | 6.02 M | 4.87 M | 23.2 M | 8.44 M | 4.83 M | 2.57 M | 2.47 M | 1.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 23.2 M | 1.8 M | 9.17 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Celsion Corporation
CLSN
|
4.62 M | - | -6.63 % | $ 13.9 M |  USA |
 |
Synthetic Biologics
SYN
|
10 M | - | 1.32 % | $ 16.2 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
78.6 M | - | - | $ 2.02 B | USA |
 |
I-Mab
IMAB
|
412 M | - | - | $ 866 M |  China |
 |
Corner Growth Acquisition Corp.
COOL
|
30.2 K | - | -0.89 % | $ 114 M | USA |
 |
AgeX Therapeutics
AGE
|
3.56 M | - | -10.17 % | $ 12.2 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | USA |
 |
Qilian International Holding Group Limited
QLI
|
41.6 M | - | -6.08 % | $ 184 M | China |
 |
Happiness Biotech Group Limited
HAPP
|
2.47 M | - | 1.35 % | $ 17.8 M | China |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
47.5 M | - | - | $ 269 M | USA |
 |
Завод ДИОД
DIOD
|
105 M | - | - | - |  Russia |
|
Galera Therapeutics
GRTX
|
645 K | - | -32.59 % | $ 7.61 M | USA |
 |
Hepion Pharmaceuticals
HEPA
|
299 K | - | -18.79 % | $ 39.3 K | USA |
 |
ARCA biopharma
ABIO
|
15.4 M | - | 1052.0 % | $ 415 M | USA |
 |
Codexis
CDXS
|
25.3 M | $ 1.46 | 2.82 % | $ 127 M | USA |
 |
Ardelyx
ARDX
|
88.6 M | $ 3.78 | 1.89 % | $ 911 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
130 M | $ 23.9 | 1.01 % | $ 3.04 B | USA |
 |
Assembly Biosciences
ASMB
|
48.8 M | $ 36.6 | 1.3 % | $ 410 M | USA |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
42.3 M | - | -1.58 % | $ 28.1 M | China |
 |
Adial Pharmaceuticals
ADIL
|
1.4 M | $ 7.12 | 6.91 % | $ 4.76 M | USA |
 |
Generation Bio Co.
GBIO
|
35.1 M | - | - | $ 344 M | USA |
 |
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
1.33 M | - | -4.36 % | $ 27 M | USA |
 |
Gracell Biotechnologies
GRCL
|
221 M | - | - | $ 3.37 B | China |
 |
Axsome Therapeutics
AXSM
|
379 M | $ 206.68 | 0.16 % | $ 10.3 B | USA |
 |
GlycoMimetics
GLYC
|
36.1 M | - | 9357.83 % | $ 1.01 B | USA |
 |
AnaptysBio
ANAB
|
38.6 M | $ 56.8 | 0.94 % | $ 1.63 B | USA |
 |
AVROBIO
AVRO
|
9.67 M | - | 1083.1 % | $ 745 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
759 M | $ 66.53 | 0.15 % | $ 12.8 B | USA |
 |
BeiGene, Ltd.
BGNE
|
1.83 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
AIkido Pharma
AIKI
|
1.61 M | - | 1.93 % | $ 17.4 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | USA |
 |
Aptose Biosciences
APTO
|
9.31 M | - | -45.71 % | $ 1.2 M |  Canada |
 |
Bicycle Therapeutics plc
BCYC
|
57 M | $ 4.3 | 1.42 % | $ 298 M |  Britain |
 |
AlloVir
ALVR
|
9.71 M | - | 4.14 % | $ 49.1 M | USA |
 |
ChromaDex Corporation
CDXC
|
19.9 M | - | -0.88 % | $ 598 M | USA |